Economic Evaluation || Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
Sonja Merkesdal, Timm Kirchhoff, Diane Wolka, Gunter Ladinek, Adrian Kielhorn and Andrea Rubbert-RothVolume:
11
Language:
english
Journal:
The European Journal of Health Economics
DOI:
10.2307/27764775
Date:
February, 2010
File:
PDF, 1.44 MB
english, 2010